Clinical trials
Brain Neoplasms trials with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
64 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 4 |
| 2017 | 9 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 9 |
| 2021 | 12 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 64 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Istanbul University | 2 |
| National Taiwan University Hospital | 2 |
| Rigshospitalet, Denmark | 2 |
| St. Joseph's Hospital and Medical Center, Phoenix | 2 |
| Sunnybrook Health Sciences Centre | 2 |
| Technical University of Munich | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
| All India Institute of Medical Sciences | 1 |
| Assiut University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 64 |
| Neoplasms | 5 |
| Breast Neoplasms | 4 |
| Neoplasm Metastasis | 4 |
| Brain Injuries | 3 |
| Central Nervous System Neoplasms | 3 |
| Glioblastoma | 3 |
| Glioma | 3 |
| Meningeal Carcinomatosis | 3 |
| Subarachnoid Hemorrhage | 3 |
Trials
Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.